| 发明名称 |
PHARMACEUTICAL COMPOSITION FOR VIRAL TREATMENT, AND METHOD FOR SCREENING ANTIVIRAL AGENT |
| 摘要 |
The present invention relates to; a pharmaceutical compostion capable of enhancing immunity against viruses by specifically decreasing the expression of the OASL1 protein; and a method for screening for a material capable of being used as an antiviral agent by comparing the amount of expression of the OASL1 protein. |
| 申请公布号 |
US2015082467(A1) |
申请公布日期 |
2015.03.19 |
| 申请号 |
US201314376987 |
申请日期 |
2013.02.13 |
| 申请人 |
Industry-Academic Cooperation Foundation, Yonsei University |
发明人 |
Kim Young-Joon;Lee Myeong Sup;Kim Byungil;Oh Goo Taeg |
| 分类号 |
C12N15/113;A01K67/027;C12Q1/68;G01N33/573;G01N33/50 |
主分类号 |
C12N15/113 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An antiviral pharmaceutical composition comprising, as active ingredients, antisense or siRNA oligonucleotide that has a sequence complementary to a nucleotide sequence of the Oasl1 gene. |
| 地址 |
Seoul KR |
